ruxolitinib

Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis




ruxolitinib

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease




ruxolitinib

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease